SEARCH

SEARCH BY CITATION

References

  • 1
    Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997; 10: 86124.
  • 2
    Rabkin JM, De La Melena V, Orloff SL, Corless CL, Rosen HR, Olyaei AJ. Late mortality after orthotopic liver transplantation. Am J Surg 2001; 181: 475479.
  • 3
    Moreno Planas JM, Rubio Gonzalez E, Herreros de Tejada A et al. Late mortality in patients with liver transplantation: Causes and risk factors. Transplant Proc 2003; 35: 707708.
  • 4
    Kirkman RL, Strom TB, Weir MR, Tilney NL. Late mortality and morbidity in recipients of long-term renal allografts. Transplantation 1982; 34: 347351.
  • 5
    Esposito S, Renzulli A, Agozzino L et al. Late complications of heart transplantation: An 11-year experience. Heart Vessels 1999; 14: 272276.
  • 6
    Bonet LA. Predictors of mortality following heart transplantation: Spanish Registry of Heart Transplantation 1984–2001. Transplant Proc 2003; 35: 19461950.
  • 7
    Gayowski T, Marino IR, Singh N et al. Orthotopic liver transplantation in high-risk patients: Risk factors associated with mortality and infectious morbidity. Transplantation 1998; 65: 499504.
  • 8
    Singh N, Gayowski T, Wagener MM, Marino IR. Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression. Eur J Clin Microbiol Infect Dis 1997; 16: 821826.
  • 9
    Abradelo M, Lumbreras C, Loinaz C, Aguado JM, Lizasoain M, Folgueira M. Late infectious complications following liver transplantation: Clinical characteristics and risk factors. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, 27–30 September 2002; San Diego , CA : American Society of Microbiology, 314.
  • 10
    RESITRA. Definiciones RESITRA. In: www.resitra.net/web/index.asp.2004. (accessed 2006 September 15). RESITRA network; 2004.
  • 11
    Troppmann C, Pierce JL, Gandhi MM, Gallay BJ, McVicar JP, Perez RV. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: A matched-pair pilot study. Transplantation 2003; 76: 426429.
  • 12
    Dean PG, Lund WJ, Larson TS et al. Wound-healing complications after kidney transplantation: A prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004; 77: 15551561.
  • 13
    Valente JF, Hricik D, Weigel K et al. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 2003; 3: 11281134.
  • 14
    Fisher A, Seguel JM, De La Torre AN et al. Effect of sirolimus on infection incidence in liver transplant recipients. Liver Transpl 2004; 10: 193198.
  • 15
    Kusne S, Dummer JS, Singh N et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988; 67: 132143.
  • 16
    Bubak ME, Porayko MK, Krom RA, Wiesner RH. Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy. Hepatology 1991; 14: 10631065.
  • 17
    Joya-Vazquez PP, Dodson FS, Dvorchik I et al. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation 2002; 73: 15981602.